Background
Holly joined Dehns as a Trainee Patent Attorney in the Biotechnology Group in June 2022. Prior to joining Dehns, she completed her PhD at the University of Edinburgh where she studied the mechanisms underlying the resolution of inflammation in skin wound healing. Specifically, her research focused on characterising the role of aberrant inflammation in chronic wounds with a goal of identifying potential therapeutic strategies targeting pro-resolving pathways to rescue the derailed healing response.
Before embarking on her doctoral studies, Holly obtained a BSc in Pharmacology from the University of Aberdeen. During her undergraduate program, she engaged in several laboratory projects including her honours project where she sought to identify whether cannabinoid receptor ligands were able to modulate insulin signalling in hepatic tissue. Holly was also awarded a scholarship to fund a summer research project where she sought to optimise microfluidic devices to allow for the co-culturing of different cell types for motor neurone disease research.
Types of clients and client work
Holly has experience working with a variety of clients including solo inventors, small/medium-sized enterprises and larger companies. She assists with the drafting, filing and prosecution of patent applications at the UKIPO and EPO. Holly also assists in the prosecution of global patent portfolios in collaboration with local agents in all key IP jurisdictions including the US, Canada, China, the Republic of Korea and Japan.
Expertise
Since joining Dehns, Holly has worked across a broad spectrum of technical areas within the field of biotechnology. Areas of experience include aspects of immunology generally, new pharmaceuticals, second medical uses, diagnostic assays, biological purifications and separations, nucleic acid manipulations and assays and cell-based therapies.
Qualifications and Memberships
PGCert Intellectual Property Law, Queen Mary University of London, 2023
Student Member of the Chartered Institute of Patent Attorneys (CIPA)
Higher Education
PhD, University of Edinburgh, 2021
BSc (Hons) Pharmacology, University of Aberdeen, 2017
Department
biotechnology